Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

248 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

NCT06583031

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +6 more
Locations
  • Site # 0361004 Botany, New South Wales, Australia
  • Site # 031001 Brookvale, New South Wales, Australia
  • Site # 0361006 Miranda, New South Wales, Australia
  • Site # 0361002 Wollongong, New South Wales, Australia
View Trial Details
Completed

A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.

NCT06473519

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Qps-Mra, Llc South Miami, Florida, United States
  • Clinical Research Atlanta Stockbridge, Georgia, United States
  • Clinical Research Prime Idaho Falls, Idaho, United States
  • Clinical Research Prime Rexburg Rexburg, Idaho, United States
View Trial Details
Completed

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

NCT06389487

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site North Hollywood, California, United States
  • GSK Investigational Site Oakland, California, United States
View all 52 locations
View Trial Details
Completed

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

NCT06237296

Conditions
Healthy Volunteers, Infections, Metapneumovirus Infection, +7 more
Locations
  • Velocity Gardena Site Number : 8400011 Gardena, California, United States
  • Velocity Clinical Research-Hallandale Beach- Site Number : 8400013 Hallandale, Florida, United States
  • Advanced Clinical Research- Site Number : 8400005 Meridian, Idaho, United States
  • Velocity Clinical Research, Sioux City Site Number : 8400017 Sioux City, Iowa, United States
View all 17 locations
View Trial Details
Completed

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

NCT04491877

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Matrix Clinical Research-Site Number:8400012 Gardena, California, United States
  • Paradigm Clinical Research-Site Number:8400026 La Mesa, California, United States
  • Matrix Clinical Research-Site Number:8400032 Los Angeles, California, United States
  • California Research Foundation-Site Number:8400016 San Diego, California, United States
View all 29 locations
View Trial Details
Completed

Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

NCT04886596

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 277 locations
View Trial Details

Related conditions